Skip to main content
TipRanks
Go Ultimate75% OFF

Tanke Biosciences (TNBI) Stock Statistics & Valuation Metrics

13 Followers

Total Valuation

Tanke Biosciences has a market cap or net worth of $584.00K. The enterprise value is $552.94B.

Market Cap
$584.00K
Enterprise Value
$552.94B

Share Statistics

Tanke Biosciences has 24,537,615 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
24,537,615
Owned by Insiders
―
Owned by Institutions
―

Financial Efficiency

Tanke Biosciences’s return on equity (ROE) is 0.69 and return on invested capital (ROIC) is 99.64%.

Return on Equity (ROE)
0.69
Return on Assets (ROA)
-3.69
Return on Invested Capital (ROIC)
99.64%
Return on Capital Employed (ROCE)
0.65
Revenue Per Employee
64.846
Profits Per Employee
-2,111.262
Employee Count
130
Asset Turnover
0.11
Inventory Turnover
0.00

Valuation Ratios

The current PE Ratio of Tanke Biosciences is -2.63. Tanke Biosciences’s PEG ratio is -0.14.

PE Ratio
-2.63
PS Ratio
0.00
PB Ratio
-1.05
Price to FCF
-485.63
Price to Operating Cash Flow
-586.06
PEG Ratio
-0.14

Income Statement

In the last 12 months, Tanke Biosciences had revenue of 8,430 and earned -274.46K in profits. Earnings per share was -0.01.

Revenue
8,430
Gross Profit
6,866
Operating Income
-257.87K
Pretax Income
-274.46K
Net Income
-274.46K
EBITDA
-256.30K
Earnings Per Share (EPS)
-0.01

Cash Flow

In the last 12 months, operating cash flow was -25.40K and capital expenditures 8, giving a free cash flow of -25.39K billion.

Operating Cash Flow
-25.40K
Free Cash Flow
-25.39K
Free Cash Flow per Share
-0.00

Dividends & Yields

Tanke Biosciences pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
-0.21%
Earnings Yield
-38.33%

Stock Price Statistics

Beta
1.82
52-Week Price Change
-48.89%
50-Day Moving Average
0.02
200-Day Moving Average
0.03
Relative Strength Index (RSI)
22.20
Average Volume (3m)
98.72K

Financial Position

Tanke Biosciences as a current ratio of 0.02, with Debt / Equity ratio of -35.10%

Current Ratio
0.02
Quick Ratio
0.02
Debt to Market Cap
0.21
Net Debt to EBITDA
-0.52
Interest Coverage Ratio
-15.53

Taxes

In the past 12 months, Tanke Biosciences has paid 0 in taxes.

Income Tax
0
Effective Tax Rate
0.00

Enterprise Valuation

Tanke Biosciences EV to EBITDA ratio is -3.03, with an EV/FCF ratio of -641.99.

EV to Sales
0.00
EV to EBITDA
-3.03
EV to Free Cash Flow
-641.99
EV to Operating Cash Flow
-642.73

Balance Sheet

Tanke Biosciences has $37.30K in cash and marketable securities with $140.00K in debt, giving a net cash position of -$102.70K billion.

Cash & Marketable Securities
$37.30K
Total Debt
$140.00K
Net Cash
-$102.70K
Net Cash Per Share
$0.00
Tangible Book Value Per Share
-$0.01

Margins

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

Gross Margin
0.00%
Operating Margin
0.00%
Pretax Margin
0.00%
Net Profit Margin
0.00%
EBITDA Margin
0.00%
EBIT Margin
0.00%

Analyst Forecast

The average price target for Tanke Biosciences is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target
―
Price Target Upside
―
Analyst Consensus
―
Analyst Count
0
Revenue Growth Forecast
-100.00%
EPS Growth Forecast
34.23%